Bucks biopharm firm signs licensing deal with California onco-immunology company

Arbutus BioPharma Corp., a Bucks County company developing treatments to cure hepatitis B infections, has entered into a collaboration and licensing deal with a California biopharmaceutical company developing personalized cancer immunotherapies. Under the terms of this license agreement, Gritstone Oncology of Emeryville, Calif., gets worldwide access to Arbutus’ portfolio of proprietary and clinically validated lipid nanoparticle [LNP] products and associated intellectual property. Gritstone will…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news